News Sight Sciences, Inc.

Equities

SGHT

US82657M1053

Real-time Estimate Cboe BZX Other stock markets 09:55:05 2024-04-26 am EDT			5-day change	1st Jan Change
5.1 ^USD	-0.78%		-0.58%	-1.16%

Apr. 10	Sight Sciences, Inc. Announces the Publication of Large-Scale, Real-World Migs Study	CI
Apr. 03	Sector Update: Health Care Stocks Flat Pre-Bell Wednesday	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sight Sciences to Report First Quarter Financial Results on May 2, 2024	Apr. 18	AQ
Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma	Apr. 10	GL
Sight Sciences, Inc. Announces the Publication of Large-Scale, Real-World Migs Study	Apr. 10	CI
Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting	Apr. 03	AQ
Sector Update: Health Care Stocks Flat Pre-Bell Wednesday	Apr. 03	MT
Sight Sciences to Present Data From Studies of Glaucoma, Dry Eye Technologies -- Shares Extend Gains to Premarket	Apr. 03	MT
Sight Sciences to Present Data From Studies of Glaucoma, Dry Eye Technologies -- Shares Jump After Hours	Apr. 02	MT
Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting	Apr. 02	AQ
Sight Sciences, Inc. Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT At the 2024 American Society of Cataract and Refractive Surgery Annual Meeting	Apr. 02	CI
Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference	Mar. 26	AQ
Stifel Adjusts Price Target on Sight Sciences to $7 From $6, Keeps Buy Rating	Mar. 08	MT
Transcript : Sight Sciences, Inc., Q4 2023 Earnings Call, Mar 07, 2024	Mar. 07
Earnings Flash (SGHT) SIGHT SCIENCES Reports Q4 Revenue $18.8M, vs. Street Est of $19.4M	Mar. 07	MT
Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2024 Financial Guidance	Mar. 07	AQ
Sight Sciences, Inc. Provides Earnings Guidance for the Year 2024	Mar. 07	CI
Sight Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07	CI
Sight Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 07	CI
Sight Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024	Feb. 22	AQ
Sight Sciences Announces European Launch of the Ergo-Series of the OMNI Surgical System at the ESCRS Winter Meeting	Feb. 15	AQ
Sight Sciences Announces European Launch of the Ergo-Series of the OMNI® Surgical System at the ESCRS Winter Meeting	Feb. 14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Sight Sciences, Inc.

Equities

SGHT

US82657M1053

Summary

Filters